You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 1, 9 JANUARY 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Methods for Standardizing Intravenous Heparin Therapy

Robert A. Raschke, MD
Phoenix, Ariz

Brendan Reilly, MD
Rochester, NY

Arch Intern Med. 1995;155(1):117.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We greatly enjoyed reading the article by Kershaw and colleagues,1 as well as the study by Elliot et al,2 each describing successful methods of standardizing heparin therapy in the treatment of deep venous thrombosis. Kershaw and colleagues1 expressed interest in a success rate analysis from our study3 on the weight-based heparin nomogram that appeared in a tabular form in our original article.

From among 62 patients randomized to treatment with the weight-based nomogram, 444 activated partial thromboplastin time (aPTT) values were obtained within 48 hours of initiation of heparin therapy. We found that 17% (77/444) of our aPTTs were subtherapeutic, 65% (288/444) were therapeutic, and 18% (79/444) were supratherapeutic. Thus, our nomogram was identically successful to computer-assisted dosing in maintaining aPTT values above the therapeutic threshold (83% of the time). We were slightly less successful in avoiding supratherapeutic aPTTs, however our definition of therapeutic range (an . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.